We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BMO:TSXBank of Montreal Analysis

Data as of 2026-09-09 - not real-time

CA$241.48

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At CAD 241.48, Bank of Montreal shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 3.7%. With RSI at 45.5 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at CAD 232.01 up to resistance at CAD 259.20.
Valuation screens as fair: a P/E of 19.7 sits above the sector average of 16.2. Consensus targets land 5.4% above where the shares trade now. Revenue is growing at 12.0% on a 25.7% profit margin. The 2.82% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 21.5%, a beta of 0.83 and a maximum drawdown of 10.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.

Top Market Events

Bank of Montreal TSX:BMO has received regulatory approval for a new normal course issuer bid to repurchase up to 25...The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...Bank of Montreal TSX:BMO has launched new leveraged and inverse ETNs offering 3× long and short exposure to major U.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 211.07
  • MACD momentum is positive
  • RSI at 45.5 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 19.7 versus sector average of 16.2
  • Trading above the 200-day average of 211.07
  • Analyst targets imply +5.4% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 19.7 versus sector average of 16.2
  • Analyst targets imply +5.4% versus the current price
  • Profit margin of 25.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth12.00%
Profit Margin25.66%
P/E Ratio19.7
ROE10.57%
ROA0.62%
P/B Ratio2.0
Op. Cash FlowCA$-4742000128
Industry P/E16.2

Technical Analysis

TrendNeutral
RSI45.5
SupportCA$232.01
ResistanceCA$259.20
MA 20CA$244.46
MA 50CA$248.81
MA 200CA$211.07
MACDBullish
VolumeStable
Fear & Greed Index93.36

Valuation

Target PriceCA$254.57
Upside/Downside5.42%
GradeFair
TypeBlend
Dividend Yield2.82%

Risk Assessment

Beta0.83
Volatility21.50%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.